Moderna Inc (NASDAQ:MRNA)
| 345.79 Delayed Data As of Jul 29 |  -3.68 / -1.05%Today’s Change | 54.21 Today|||52-Week Range 362.00 | +230.99% Year-to-Date |
Latest MRNA News | Press Releases
| Pharma & Healthcare ETFs at a One-Year High: Here's Why 8:00am / Zacks.com - Paid Partner Content | Moderna (MRNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Jul 29 / Zacks.com - Paid Partner Content |
| Will Moderna Be a Trillion-Dollar Stock by 2030? 7:39am / MotleyFool.com - Paid Partner Content | What Does Moderna's Addition to the S&P 500 Mean for Investors? Jul 29 / MotleyFool.com - Paid Partner Content |
| Is a Meltdown on the Way for Moderna Stock? 5:52am / MotleyFool.com - Paid Partner Content | Is Moderna a Buy? Jul 29 / MotleyFool.com - Paid Partner Content |
| Why Moderna and BioNTech Slipped Today Jul 29 / MotleyFool.com - Paid Partner Content | Is Novavax a Buy? Jul 29 / MotleyFool.com - Paid Partner Content |
| Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know Jul 29 / Zacks.com - Paid Partner Content | These Ultra-Popular Stocks May Fall 50% to 97%, According to Wall Street Jul 29 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 349.32 |
| Today’s open | 350.64 |
| Day’s range | 336.00 - 351.22 |
| Volume | 10,100,729 |
| Average volume (3 months) | 11,779,475 |
| Market cap | $140.1B |
Data as of 4:39pm ET, 07/29/2021
Growth & Valuation
| Earnings growth (last year) | -26.08% |
| Earnings growth (this year) | +1,435.38% |
| Earnings growth (next 5 years) | +33.60% |
| Revenue growth (last year) | +1,234.34% |
| P/E ratio | 281.1 |
| Price/Sales | 49.59 |
| Price/Book | 54.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMGNAmgen | -1.79 | -0.73% |
| GILDGilead Sciences | -0.23 | -0.33% |
| ILMNIllumina Inc | -0.59 | -0.12% |
| BIIBBiogen | -5.01 | -1.50% |
Data as of 5:05pm ET, 07/29/2021
Financials
| Next reporting date | August 5, 2021 |
| EPS forecast (this quarter) | $5.96 |
| Annual revenue (last year) | $803.4M |
| Annual profit (last year) | -$747.1M |
| Net profit margin | -92.99% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
